CRL - Charles River Laboratories International, Inc.

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,976,060
3,976,060
3,540,160
2,923,933
2,621,226
Cost of revenue
2,513,409
2,513,409
2,205,522
1,850,392
1,662,915
Gross profit
1,462,651
1,462,651
1,334,638
1,073,541
958,311
Operating expenses
Selling general and administrative
665,098
665,098
619,919
528,935
517,622
Total operating expenses
811,676
811,676
744,776
640,812
607,160
Operating income or loss
650,975
650,975
589,862
432,729
351,151
Interest expense
59,291
59,291
73,910
86,433
60,882
Total other income/expenses net
30,523
30,523
-35,894
99,984
12,293
Income before tax
622,987
622,987
480,710
447,114
304,084
Income tax expense
130,379
130,379
81,873
81,808
50,023
Income from continuing operations
492,608
492,608
398,837
365,306
254,061
Net income
486,226
486,226
390,982
364,304
252,019
Net income available to common shareholders
486,226
486,226
390,982
364,304
252,019
Basic EPS
-
-
7.77
7.35
5.17
Diluted EPS
-
-
7.60
7.20
5.07
Basic average shares
-
-
50,293
49,550
48,730
Diluted average shares
-
-
51,425
50,611
49,693
EBITDA
-
986,148
820,160
768,471
563,061